New Nordic Healthbrands AB (SE:NNH)
:NNH
Top Page
New Nordic Healthbrands AB
(NNH)
Select Model
Select Model
Rating:57Neutral
Price Target:
kr18.50
▼(-13.95% Downside)
Action:ReiteratedDate:03/02/26
The score is driven primarily by improving but still inconsistent fundamentals: strong revenue growth and moderate leverage are offset by volatile profitability and uneven cash flow, with added concern from the 2025 gross margin drop. Technically, the stock shows a short-term rebound but remains below longer-term averages and momentum appears stretched. Valuation is reasonable based on the 14.93 P/E, providing modest support.
Positive Factors
Revenue Growth
Sustained top-line expansion, including a 16.9% YoY revenue increase in 2025, indicates genuine demand growth and expanding market penetration. Over 2–6 months this supports durable earnings potential and gives management room to invest in scale, product distribution, and margin recovery initiatives.
Negative Factors
Margin Compression
A pronounced gross margin decline is a structural concern because it directly reduces operating leverage and profitability. If cost pressures or adverse product mix persist, the company’s ability to sustain recent profit recovery is at risk, impairing long-term margin restoration and cash generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained top-line expansion, including a 16.9% YoY revenue increase in 2025, indicates genuine demand growth and expanding market penetration. Over 2–6 months this supports durable earnings potential and gives management room to invest in scale, product distribution, and margin recovery initiatives.
Read all positive factors
New Nordic Healthbrands AB (NNH) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr110.27M
Dividend YieldN/A
Average Volume (3M)5.45K
Price to Earnings (P/E)17.5
Beta (1Y)0.19
Revenue Growth5.91%
EPS GrowthN/A
CountrySE
Employees77
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.33
Shares Outstanding6,195,200
10 Day Avg. Volume3,153
30 Day Avg. Volume5,451
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.39
Price to Sales (P/S)0.25
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
New Nordic Healthbrands AB Business Overview & Revenue Model
Company Description
New Nordic Healthbrands AB (publ) develops and markets dietary supplements, natural medicines, and cosmetic products in Sweden. The company provides vitality products for immune system. The company provides balm, repair mask, shampoo, shine serum,...
How the Company Makes Money
null...
New Nordic Healthbrands AB Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
68
Positive
Cash Flow
49
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 576.36M | 550.31M | 533.85M | 487.50M | 514.85M |
| Gross Profit | 15.15M | 354.69M | 348.23M | 318.50M | 350.05M |
| EBITDA | 17.61M | -1.43M | -1.94M | -2.57M | 29.34M |
| Net Income | 8.20M | -7.70M | -6.19M | -2.82M | 21.30M |
Balance Sheet | |||||
| Total Assets | 246.15M | 248.72M | 249.06M | 251.67M | 238.35M |
| Cash, Cash Equivalents and Short-Term Investments | 16.55M | 15.25M | 13.81M | 10.70M | 11.88M |
| Total Debt | 35.84M | 39.22M | 26.64M | 48.35M | 24.43M |
| Total Liabilities | 142.69M | 148.19M | 143.03M | 139.10M | 118.03M |
| Stockholders Equity | 103.47M | 100.92M | 106.03M | 112.57M | 120.32M |
Cash Flow | |||||
| Free Cash Flow | 7.57M | -6.62M | 25.88M | -18.41M | -10.58M |
| Operating Cash Flow | 8.39M | -5.40M | 28.03M | -15.45M | -7.87M |
| Investing Cash Flow | -3.22M | -3.71M | -3.40M | -2.62M | -2.97M |
| Financing Cash Flow | -3.38M | 10.39M | -21.17M | 16.59M | 12.07M |
New Nordic Healthbrands AB Technical Analysis
Neutral
21.50
Price Trends
17.70
Positive
19.48
Negative
21.28
Negative
Market Momentum
-0.26
Negative
51.02
Neutral
98.92
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NNH, the sentiment is Neutral. The current price of 21.5 is above the 20-day moving average (MA) of 17.65, above the 50-day MA of 17.70, and above the 200-day MA of 21.28, indicating a neutral trend. The MACD of -0.26 indicates Negative momentum. The RSI at 51.02 is Neutral, neither overbought nor oversold. The STOCH value of 98.92 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:NNH.
New Nordic Healthbrands AB Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | kr1.37B | 17.84 | ― | 4.05% | 12.49% | 116.06% | |
68 Neutral | kr1.96B | 9.34 | -0.17% | 2.34% | -2.95% | -112.90% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | kr599.50M | 58.47 | ― | 2.43% | ― | ― | |
57 Neutral | kr110.27M | 17.54 | ― | ― | 5.91% | ― | |
56 Neutral | kr525.02M | 21.64 | ― | 0.51% | 22.02% | 127.51% | |
50 Neutral | kr3.26B | 204.56 | 0.87% | ― | 5.99% | -38.16% |
* Consumer Defensive Sector Average
SE:NNH
New Nordic Healthbrands AB
17.80
3.90
28.06%
SE:MSON.B
Midsona AB Class B
13.45
4.59
51.84%
SE:HUMBLE
Humble Group AB
7.30
-0.70
-8.75%
SE:SKMO
Skane-moellan AB
54.50
-3.94
-6.74%
SE:CHEF
Cheffelo AB
105.60
67.70
178.62%
SE:SNX
Premium Snacks Nordic AB
38.60
15.25
65.31%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.